HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Taupitz Selected Research

contrast agent P792

4/2007Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
4/2004Assessment of myocardial infarction in pigs using a rapid clearance blood pool contrast medium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Taupitz Research Topics

Disease

10Inflammation (Inflammations)
10/2022 - 12/2008
8Neoplasms (Cancer)
12/2020 - 07/2006
8Myocardial Infarction
04/2014 - 04/2004
7Infarction (Infarctions)
01/2013 - 04/2004
6Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2022 - 08/2009
6Body Weight (Weight, Body)
12/2019 - 12/2002
5Prostatic Neoplasms (Prostate Cancer)
10/2019 - 09/2002
4Atherosclerosis
09/2021 - 12/2008
4Atherosclerotic Plaque (Atheroma)
01/2021 - 05/2011
4Pathologic Constriction (Stenosis)
10/2020 - 10/2007
3Multiple Sclerosis
10/2022 - 08/2009
3Experimental Arthritis
10/2012 - 01/2006
2Neuroinflammatory Diseases
10/2022 - 01/2019
2Nephrogenic Fibrosing Dermopathy
07/2014 - 03/2013
2Carcinoma (Carcinomatosis)
07/2006 - 02/2005
1Alzheimer Disease (Alzheimer's Disease)
01/2022
1Rupture
01/2022
1Aortic Aneurysm (Aneurysm, Aortic)
01/2022
1Aneurysm (Aneurysms)
10/2020
1Amyloidosis
10/2019
1Encephalitis (Encephalitis, Rasmussen)
10/2019
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
06/2016
1Myeloid Leukemia (Leukemia, Myelocytic)
08/2014
1Ischemia
03/2014
1Arthritis (Polyarthritis)
12/2009
1Rheumatoid Arthritis
12/2009
1Amyloid Plaque
06/2009
1Vascular Remodeling
05/2009
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2009
1Neoplasm Metastasis (Metastasis)
07/2008
1Peripheral Arterial Occlusive Disease 1
11/2007
1Leiomyoma (Uterine Fibroids)
10/2006
1Phobic Disorders (Phobia)
05/2006
1Joint Diseases (Joint Disease)
01/2006
1Lyme Disease (Disease, Lyme)
01/2006
1Insulin Resistance
10/2005
1Fatty Liver
10/2005

Drug/Important Bio-Agent (IBA)

14Contrast MediaIBA
01/2021 - 04/2004
10GadoliniumIBA
10/2022 - 05/2011
6gadobutrolIBA
10/2022 - 09/2003
6Gadolinium DTPA (Magnevist)FDA Link
10/2022 - 07/2006
5ferric oxide (iron oxide)IBA
03/2014 - 07/2008
4gadobenic acid (gadobenate dimeglumine)FDA Link
07/2008 - 12/2002
3Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2009
3IronIBA
01/2021 - 11/2004
3ferumoxides (Feridex)FDA Link
10/2020 - 07/2006
3triphenyltetrazoliumIBA
06/2009 - 06/2006
2gadofosveset trisodium (MS 325)FDA Link
09/2021 - 07/2009
2gadoterate meglumineIBA
01/2013 - 04/2004
2gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
01/2013 - 04/2004
2Citric Acid (Citrate)FDA LinkGeneric
01/2013 - 07/2008
2Coloring Agents (Dyes)IBA
10/2012 - 01/2006
2contrast agent P792IBA
04/2007 - 04/2004
2Prostate-Specific Antigen (Semenogelase)IBA
02/2005 - 09/2002
1Peptide LibraryIBA
01/2022
1FibrinIBA
01/2022
1Pravastatin (Pravachol)FDA LinkGeneric
09/2021
1Ferrosoferric Oxide (Magnetite)FDA Link
09/2021
1AlbuminsIBA
09/2021
1OxidesIBA
01/2021
1Molecular Probes (Molecular Probe)IBA
12/2020
1Complement System Proteins (Complement)IBA
10/2019
1EuropiumIBA
01/2019
1Inositol (Myoinositol)IBA
01/2018
1prostaglandin G2IBA
01/2018
1GlycosaminoglycansIBA
01/2017
1Paclitaxel (Taxol)FDA LinkGeneric
06/2016
1L-SelectinIBA
08/2014
1Biological ProductsIBA
03/2013
1trans-sodium crocetinate (crocetin)IBA
10/2012
1Epoxy ResinsFDA Link
09/2012
1Durapatite (Hydroxylapatite)IBA
09/2012
1Phenobarbital (Luminal)FDA Link
09/2012
1Apolipoproteins E (ApoE)IBA
05/2011
1Immunoglobulin FragmentsIBA
12/2009
1Extracellular Matrix ProteinsIBA
12/2009
1Fibronectins (Fibronectin)IBA
12/2009
1TungstenIBA
06/2009
1Tyrosine Kinase InhibitorsIBA
05/2009
1Sunitinib (Sutent)FDA Link
05/2009
1Bevacizumab (Avastin)FDA Link
05/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2009
1EnzymesIBA
12/2008
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
12/2008
1gadolinium ethoxybenzyl DTPAFDA Link
11/2008
1A-factor (Streptomyces)IBA
06/2006
11,1'- bis- (4- sulfobutyl)indotricarbocyanine- 5,5'- dicarboxylic acid diglucamideIBA
01/2006
1LipidsIBA
10/2005

Therapy/Procedure

6Therapeutics
12/2020 - 06/2004
2Injections
10/2022 - 10/2019
2Prostatectomy (Retropubic Prostatectomy)
10/2019 - 01/2018
2Lasers (Laser)
05/2012 - 01/2006
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
11/2009
1Radiotherapy
11/2009
1Ligation
06/2009
1Intraventricular Injections
06/2009
1Thoracotomy
06/2009
1Intravenous Injections
11/2008
1Contraindications
05/2006